KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Net Income towards Common Stockholders: 2017-2025

Historic Net Income towards Common Stockholders for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -$200.0 million.

  • Moderna's Net Income towards Common Stockholders fell 1638.46% to -$200.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 billion, marking a year-over-year decrease of 40.11%. This contributed to the annual value of -$3.6 billion for FY2024, which is 24.46% up from last year.
  • As of Q3 2025, Moderna's Net Income towards Common Stockholders stood at -$200.0 million, which was up 75.76% from -$825.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Net Income towards Common Stockholders registered a high of $4.9 billion during Q4 2021, and its lowest value of -$3.6 billion during Q3 2023.
  • In the last 3 years, Moderna's Net Income towards Common Stockholders had a median value of -$971.0 million in 2025 and averaged -$933.7 million.
  • As far as peak fluctuations go, Moderna's Net Income towards Common Stockholders spiked by 2,476.07% in 2021, and later crashed by 1,638.46% in 2025.
  • Quarterly analysis of 5 years shows Moderna's Net Income towards Common Stockholders stood at $4.9 billion in 2021, then crashed by 69.91% to $1.5 billion in 2022, then slumped by 85.19% to $217.0 million in 2023, then plummeted by 616.13% to -$1.1 billion in 2024, then tumbled by 1,638.46% to -$200.0 million in 2025.
  • Its last three reported values are -$200.0 million in Q3 2025, -$825.0 million for Q2 2025, and -$971.0 million during Q1 2025.